(Q67765346)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1744165%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Production of interleukin-1 beta and tumour necrosis factor-alpha in patients with benign or malignant ovarian tumours (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1744165%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Production of interleukin-1β and tumour necrosis factor-α in patients with benign or malignant ovarian tumours (English)

1 reference

14 November 2022

1 reference

14 November 2022

author name string

J. Punnonen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1744165

14 November 2022

P. K. Heinonen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1744165

14 November 2022

T. Kuoppala

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1744165

14 November 2022

C. T. Jansen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1744165

14 November 2022

R. Punnonen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1744165

14 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1744165

14 November 2022

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1744165%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 September 2019

http://link.springer.com/content/pdf/10.1007/BF01613293.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF01613293/fulltext.html

14 November 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF01613293

14 November 2022

1 reference

Journal of Cancer Research and Clinical Oncology

14 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1744165%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1744165%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1744165%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

587-592

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1744165%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01613293

17 September 2019

exact match

0 references

cites work

Synergy of human recombinant interleukin 1 with interleukin 2 in the generation of lymphokine-activated killer cells

1 reference

12 December 2020

Tumor necrosis factor in children with malignancies.

1 reference

12 December 2020

Role of interleukin 1 in promoting human monocyte-mediated tumor cytotoxicity

1 reference

12 December 2020

Human interferon as a therapeutic agent: a decade passes

1 reference

12 December 2020

Two distinct factors are required for induction of T-cell growth

1 reference

12 December 2020

Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α

1 reference

12 December 2020

Immunotherapy of cancer using interleukin 2: current status and future prospects

1 reference

12 December 2020

Detection of tumour necrosis factor-like cytotoxicity in serum from patients with septicaemia but not from untreated cancer patients

1 reference

12 December 2020

Raised serum levels of tumour necrosis factor in parasitic infections

1 reference

12 December 2020

The biology of interleukin 1 and comparison to tumor necrosis factor

1 reference

12 December 2020

Secretory products of macrophages

1 reference

12 December 2020

Combination immunotherapy for non-small cell lung cancer. Results with interleukin-2 and tumor necrosis factor-alpha

1 reference

12 December 2020

Interleukin-1 beta induces tumor necrosis and early morphologic and metabolic changes in transplantable mouse tumors. Similarities with the anti-tumor effects of tumor necrosis factor alpha or beta

1 reference

12 December 2020

Serum levels of tumor necrosis factor-alpha in hairy cell leukemia.

1 reference

12 December 2020

EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER

1 reference

12 December 2020

Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice

1 reference

12 December 2020

Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity

1 reference

12 December 2020

Interleukin 1: the first interleukin.

1 reference

12 December 2020

Reduced production of tumor necrosis factor by mononuclear cells in hairy cell leukemia patients and improvement following interferon therapy

1 reference

12 December 2020

Human interleukin 1 is a cytocidal factor for several tumor cell lines.

1 reference

12 December 2020

In situ detection of tumour necrosis factor in human ovarian cancer specimens

1 reference

12 December 2020

Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate.

1 reference

12 December 2020

Modulation of the growth of transformed cells by human tumor necrosis factor-alpha and interferon-gamma.

1 reference

12 December 2020

Detection of tumour necrosis factor/cachectin in pleural effusion of patients with lung cancer

1 reference

12 December 2020

Interleukin-1 alpha and tumor necrosis factor-alpha protect cells against natural killer cell-mediated cytotoxicity and natural killer cytotoxic factor.

1 reference

12 December 2020

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

12 December 2020

Cachectin/tumour-necrosis-factor production by cancer patients

1 reference

12 December 2020

Phase I study of recombinant human tumor necrosis factor alpha in advanced malignant disease

1 reference

12 December 2020

Regulation of lymphocyte tumor necrosis factor receptors by IL-2

1 reference

12 December 2020

Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1

1 reference

12 December 2020

Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

1 reference

12 December 2020

Cells secreting tumour necrosis factor show enhanced metastasis in nude mice

1 reference

12 December 2020

Phase I trial of recombinant human gamma-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer

1 reference

12 December 2020

Interleukin 1 promotes tumor cell adhesion to cultured human endothelial cells

1 reference

12 December 2020

There is more than one interleukin 1.

1 reference

12 December 2020

Regulation of tumor necrosis factor gene expression in colorectal adenocarcinoma: in vivo analysis by in situ hybridization

1 reference

12 December 2020

High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia

1 reference

12 December 2020

Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells

1 reference

12 December 2020

Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01613293

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1744165%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference